About | Free Trial

Last Update

2016-05-17T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Michel Marre?

Dr. Michel Marre

Head of the Endocrinology

Diabetology

Diabetology

Background Information

Employment History

Professor of Endocrinology
Xavier-Bichat

Affiliations

Scientific Advisory Board Member
Prognomix inc

Scientific and Clinical Advisor
Pharnext

Education

MD

Web References (11 Total References)


Scientific Advisory Board : Prognomix

www.prognomix.com [cached]

Dr. Michel Marre, Professor and Head of Endocrinology, Diabetology and Metabolic Disorders Department, Bichat-Claude Bernard Hospital and Director of the INSERM Research Unit U695, Paris, France


Scientific and Clinical Advisors

www.pharnext.com [cached]

Professor Michel Marre Bichat-Claude Bernard Hospital, Paris

World expert in diabetes and related complications, notably nephropathy. Head of Endocrinology, Diabetology and Metabolic Disorders Departement at the Bichat-Claude Bernard Hospital, Paris.


Aiming for a Paris diabetes research strategy

www.parisdeveloppement.com [cached]

"French - in particular Paris-based - diabetologists do not realize the importance of clinical research and interdisciplinary cooperation, with the cardiovascular field for example," complains Michel Marre, head of the Endocrinology, Diabetology and Metabolic Disorders department of Bichat-Claude Bernard hospital and director of INSERM Unit 695: Genetic Causes of Type II Diabetes and its Vascular Complications.

...
At Bichat-Claude Bernard hospital in Paris North, the aforementioned team led by Michel Marre has only 15 scientists but specializes in international clinical research on the vascular complications of diabetes.
...
In any event, the idea is catching on: Michel Marre at Bichat also intends to set up a centre that will bring together the Paris North forces (Bichat, Lariboisière and Robert Debré).


Glipizide in Patients with Type 2 ...

www.newswise.com [cached]

Glipizide in Patients with Type 2 Diabetes and Moderate to Severe Chronic Renal Insufficiency" (abstract LB-PO3166) include Juan Arjona Ferreira, MD, Michel Marre, MD, PhD, George Bakris, MD, and Ton Rabelink, MD, PhD.

...
Michel Marre receives honoraria from is a scientific advisor for or has other relationships with Abbott, Eli Lilly, MSD, Novo Nordisk, Sanofi Aventis, and Servier.


Glipizide in Patients with Type 2 ...

www.newswise.com [cached]

Glipizide in Patients with Type 2 Diabetes and Moderate to Severe Chronic Renal Insufficiency" (abstract LB-PO3166) include Juan Arjona Ferreira, MD, Michel Marre, MD, PhD, George Bakris, MD, and Ton Rabelink, MD, PhD.

...
Michel Marre receives honoraria from is a scientific advisor for or has other relationships with Abbott, Eli Lilly, MSD, Novo Nordisk, Sanofi Aventis, and Servier.

Similar Profiles

Other People with this Name

Other people with the name Marre

Daniel Marre
Perkins Coie LLP

Martine De Marre
University of South Africa

Daniel Marre
Sony Mobile Communications Inc

Christof Marré
EMD Serono , Inc.

Patrick Marre
VanderHouwen & Associates Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory